Literature DB >> 22253279

Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study.

Natalie Spomer1, Viviane Klingmann, Ines Stoltenberg, Christian Lerch, Thomas Meissner, Joerg Breitkreutz.   

Abstract

OBJECTIVE: To explore the acceptance of uncoated drug-free mini-tablets 2 mm in diameter in children aged 0.5-6 years and their ability to swallow the mini-tablets.
METHODS: 60 children aged 0.5-6 years (10 subjects per year of life) were enrolled in our prospective, open random, two-way cross-over exploratory pilot study. The children were administered either an uncoated drug-free mini-tablet 2 mm in diameter with a beverage of their choice or 3 ml of glucose syrup 15% followed by the other formulation. Deglutition was visually assessed for the two different dosage forms using a predefined criteria list.
RESULTS: The study hypothesis was that children would accept the liquid formulation better than the solid mini-tablets. Surprisingly, the authors found that the acceptance of the mini-tablets, defined as immediate swallowing or chewing first with subsequent swallowing, was higher or at least equal to that of the syrup. Very young children (6-12 months) were fully capable of swallowing the mini-tablets and may even accept them better than the sweet liquid formulation. Some children aged between 2 and 4 years chewed the tablets before swallowing, but still accepted them quite well. The acceptance rate of the mini-tablets in the different age groups was much higher than expected.
CONCLUSIONS: Uncoated mini-tablets seem to be a very promising alternative to liquid formulations and could be used at an earlier age in paediatric drug therapy than previously anticipated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22253279     DOI: 10.1136/archdischild-2011-300958

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  26 in total

Review 1.  Formulations for children: problems and solutions.

Authors:  Hannah K Batchelor; John F Marriott
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

2.  Problems with oral formulations prescribed to children: a focus group study of healthcare professionals.

Authors:  Rebecca Venables; Heather Stirling; Hannah Batchelor; John Marriott
Journal:  Int J Clin Pharm       Date:  2015-07-15

Review 3.  Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use.

Authors:  Maren Preis
Journal:  AAPS PharmSciTech       Date:  2015-03-05       Impact factor: 3.246

Review 4.  Methodology Used to Assess Acceptability of Oral Pediatric Medicines: A Systematic Literature Search and Narrative Review.

Authors:  Punam Mistry; Hannah Batchelor
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

Review 5.  Educational paper: formulation-related issues in pediatric clinical pharmacology.

Authors:  Catherine Tuleu; Joerg Breitkreutz
Journal:  Eur J Pediatr       Date:  2012-10-31       Impact factor: 3.183

6.  Challenges and opportunities in the design of age-appropriate drug products.

Authors:  S Stegemann
Journal:  Z Gerontol Geriatr       Date:  2012-08       Impact factor: 1.281

7.  Development of a Pediatric Mini-Tablet Formulation for Expedited Preclinical Studies.

Authors:  Monika Lavan; Xueqi Wang; Robyn McCain; Amber Jannasch; Bruce Cooper; Scott Hostetler; Stephen Byrn; Gregory Knipp
Journal:  AAPS PharmSciTech       Date:  2021-01-08       Impact factor: 3.246

Review 8.  A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms.

Authors:  Anne Zajicek; Michael J Fossler; Jeffrey S Barrett; Jeffrey H Worthington; Robert Ternik; Georgia Charkoftaki; Susan Lum; Jörg Breitkreutz; Mike Baltezor; Panos Macheras; Mansoor Khan; Shreeram Agharkar; David Douglas MacLaren
Journal:  AAPS J       Date:  2013-08-02       Impact factor: 4.009

9.  Solid oral forms availability in children: a cost saving investigation.

Authors:  Audrey Lajoinie; Emilie Henin; Behrouz Kassai; David Terry
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

10.  Dosage form preference consultation study in children and young adults: paving the way for patient-centred and patient-informed dosage form development.

Authors:  Hamad Alyami; Eman Dahmash; Fahad Alyami; Dania Dahmash; Chi Huynh; David Terry; Afzal R Mohammed
Journal:  Eur J Hosp Pharm       Date:  2016-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.